| 12/06/25 | GSK | 11:00:00 | 12 Jun 2025 | | GSK | Director/PDMR Shareholding | GSK plc | PRN |
| 25/05/22 | GSK | 15:41:00 | 25 May 2022 | | GSK | Director/PDMR Shareholding | GSK plc | PRN |
| 01/12/21 | GSK | 11:05:00 | 1 Dec 2021 | | GSK | Total Voting Rights | GSK plc | PRN |
| 09/04/21 | | 17:34:47 | 9 Apr 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 09/04/21 | | 13:35:58 | 9 Apr 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 06/04/21 | | 14:30:06 | 6 Apr 2021 | | | Directorate Change | GlaxoSmithKline PLC | RNS |
| 01/04/21 | | 15:36:34 | 1 Apr 2021 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 30/03/21 | | 16:21:03 | 30 Mar 2021 | | | Publication of 2021 AGM Notice | GlaxoSmithKline PLC | RNS |
| 30/03/21 | | 11:30:01 | 30 Mar 2021 | | | GSK respiratory product sales reporting changes | GlaxoSmithKline PLC | RNS |
| 24/03/21 | | 12:30:04 | 24 Mar 2021 | | | Moncef Slaoui Departs Galvani Bioelectronics | GlaxoSmithKline PLC | RNS |
| 23/03/21 | | 16:31:13 | 23 Mar 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 17/03/21 | | 18:24:40 | 17 Mar 2021 | | | Chair of Audit & Risk Committee | GlaxoSmithKline PLC | RNS |
| 16/03/21 | | 11:08:41 | 16 Mar 2021 | | | Medicago and GSK start Phase 3 trial | GlaxoSmithKline PLC | RNS |
| 15/03/21 | | 17:27:01 | 15 Mar 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 15/03/21 | | 07:00:05 | 15 Mar 2021 | | | Annual Report 2020 on Form 20-F | GlaxoSmithKline PLC | RNS |
| 11/03/21 | | 14:25:39 | 11 Mar 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 11/03/21 | | 07:00:04 | 11 Mar 2021 | | | GSK and Vir share positive VIR-7831 data in COVID | GlaxoSmithKline PLC | RNS |
| 10/03/21 | | 13:23:33 | 10 Mar 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 09/03/21 | | 13:43:44 | 9 Mar 2021 | | | Annual Financial Report | GlaxoSmithKline PLC | RNS |
| 02/03/21 | | 15:48:46 | 2 Mar 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 01/03/21 | | 10:55:51 | 1 Mar 2021 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 25/02/21 | | 12:00:05 | 25 Feb 2021 | | | GSK announces otilimab data for treatment of COVID | GlaxoSmithKline PLC | RNS |
| 24/02/21 | | 13:59:01 | 24 Feb 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 24/02/21 | | 12:13:49 | 24 Feb 2021 | | | Holding(s) in Company | GlaxoSmithKline PLC | RNS |
| 23/02/21 | | 09:03:37 | 23 Feb 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 22/02/21 | | 16:39:33 | 22 Feb 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 22/02/21 | | 10:40:01 | 22 Feb 2021 | | | Sanofi and GSK initiate new Phase 2 study | GlaxoSmithKline PLC | RNS |
| 19/02/21 | | 12:52:20 | 19 Feb 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 19/02/21 | | 12:31:39 | 19 Feb 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 19/02/21 | | 10:32:35 | 19 Feb 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 18/02/21 | | 09:59:14 | 18 Feb 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 17/02/21 | | 12:00:01 | 17 Feb 2021 | | | GSK/Vir collaborate on antibodies for influenza | GlaxoSmithKline PLC | RNS |
| 17/02/21 | | 09:00:02 | 17 Feb 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 15/02/21 | | 10:09:54 | 15 Feb 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 15/02/21 | | 09:15:24 | 15 Feb 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/02/21 | | 16:26:49 | 12 Feb 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/02/21 | | 16:23:56 | 12 Feb 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/02/21 | | 16:20:23 | 12 Feb 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 10/02/21 | | 17:05:07 | 10 Feb 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 10/02/21 | | 16:54:19 | 10 Feb 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 04/02/21 | | 11:15:02 | 4 Feb 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 03/02/21 | | 12:00:01 | 3 Feb 2021 | | | Final Results | GlaxoSmithKline PLC | RNS |
| 03/02/21 | | 07:00:03 | 3 Feb 2021 | | | GSK/CureVac partner on new mRNA Covid-19 vaccines | GlaxoSmithKline PLC | RNS |
| 01/02/21 | | 14:04:37 | 1 Feb 2021 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 26/01/21 | | 16:26:39 | 26 Jan 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 22/01/21 | | 07:00:06 | 22 Jan 2021 | | | FDA approves ViiV Healthcare’s Cabenuva for HIV | GlaxoSmithKline PLC | RNS |
| 20/01/21 | | 16:00:47 | 20 Jan 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/01/21 | | 15:50:11 | 20 Jan 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/01/21 | | 15:02:17 | 20 Jan 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 19/01/21 | | 18:02:19 | 19 Jan 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |